帕金森病基因治疗新进展

[1] 左旋多巴治疗帕金森病若干问题的新认识 [J]. 国际神经病学神经外科学杂志, 2006, (05) : 417 - 420

[2] TH和GDNF双转基因工程细胞对多巴胺能神经元的保护作用 [J]. 临床神经外科杂志, 2004, (04) : 160 - 162

[3] TH基因修饰的神经干细胞移植治疗帕金森病的实验研究 [J]. 中华神经外科杂志, 2003, (05) : 58 - 62

[4] The parkin protein as a therapeutic target in Parkinson's disease [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2007, 11 (12) : 1543 - 1552

[5] Doxycycline-regulated co-expression of GDNF and TH in PC12 cells[J] . Jian-jun Wang,Ting Zhang,Dong-bin Niu,Kun Wang,Kai-rong Li,Bing Xue,Xiao-min Wang.Neuroscience Letters . 2006 (1)

[6] Tyrosine hydroxylase replacement in experimental Parkinson's disease with transvascular gene therapy [J]. NeuroRX, 2005, 2 (1): : 129 - 138

[7] Comparison of the capability of GDNF, BDNF, or both, to protect nigrostriatal neurons in a rat model of Parkinson's disease[J] . Mei Sun,Lingxin Kong,Xiaodan Wang,Xiu-gui Lu,Qingsheng Gao,Alfred I. Geller.Brain Research . 2005 (2)

[8] Mice lacking α-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration [J]. NEUROTOXICOLOGY, 2004, 25 (05) : 761 - 769

[9] Is levodopa toxic?[J] . Thomas Müller,Harald Hefter,Roland Hueber,Wolfgang H. Jost,Klaus L. Leenders,Per Odin,Johannes Schwarz.Journal of Neurology . 2004 (6)

[10] Brain-derived neu-rotrophic factor and glial cell line-derived neurotrophic factor are required simultaneously for survival of dopaminergic primary sensory neurons in vivo .2 Erickson JT,Brosenitsch TA,Katz DM. J Neurosci . 2001

[1] 左旋多巴治疗帕金森病若干问题的新认识 [J]. 国际神经病学神经外科学杂志, 2006, (05) : 417 - 420

[2] TH和GDNF双转基因工程细胞对多巴胺能神经元的保护作用 [J]. 临床神经外科杂志, 2004, (04) : 160 - 162

[3] TH基因修饰的神经干细胞移植治疗帕金森病的实验研究 [J]. 中华神经外科杂志, 2003, (05) : 58 - 62

[4] The parkin protein as a therapeutic target in Parkinson's disease [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2007, 11 (12) : 1543 - 1552

[5] Doxycycline-regulated co-expression of GDNF and TH in PC12 cells[J] . Jian-jun Wang,Ting Zhang,Dong-bin Niu,Kun Wang,Kai-rong Li,Bing Xue,Xiao-min Wang.Neuroscience Letters . 2006 (1)

[6] Tyrosine hydroxylase replacement in experimental Parkinson's disease with transvascular gene therapy [J]. NeuroRX, 2005, 2 (1): : 129 - 138

[7] Comparison of the capability of GDNF, BDNF, or both, to protect nigrostriatal neurons in a rat model of Parkinson's disease[J] . Mei Sun,Lingxin Kong,Xiaodan Wang,Xiu-gui Lu,Qingsheng Gao,Alfred I. Geller.Brain Research . 2005 (2)

[8] Mice lacking α-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration [J]. NEUROTOXICOLOGY, 2004, 25 (05) : 761 - 769

[9] Is levodopa toxic?[J] . Thomas Müller,Harald Hefter,Roland Hueber,Wolfgang H. Jost,Klaus L. Leenders,Per Odin,Johannes Schwarz.Journal of Neurology . 2004 (6)

[10] Brain-derived neu-rotrophic factor and glial cell line-derived neurotrophic factor are required simultaneously for survival of dopaminergic primary sensory neurons in vivo .2 Erickson JT,Brosenitsch TA,Katz DM. J Neurosci . 2001